First-in-human Trial of STC-1010, an Immunotherapy, in Patients With Unresectable Locally Advanced or Metastatic Colorectal Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Institut Jules Bordet
Brussels, Belgium
Not, yet, recruiting
- Institut Bergonié
Bordeaux, France
Recruiting - Centre Georges François Leclerc (cgfl)
Dijon, France
Recruiting - Centre Léon Bérard (clb)
Lyon, France
Not, yet, recruiting - Hospices Civils de Lyon (hcl)
Lyon, France
Recruiting - Institut Du Cancer de Montpellier (icm)
Montpellier, France
Recruiting - Centre Hospitalier Universitaire de Poitiers (chu)
Poitiers, France
Not, yet, recruiting - Institut Gustave Roussy (igr)
Villejuif, France
Recruiting
- Johns Hopkins
Baltimore, Maryland, United States
Not, yet, recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 17 Jun 2025
- Primary completion
- 30 Jun 2028
- Completion
- 30 Jun 2029
- Last update posted
- 22 Dec 2025
- Registered enrollment
- 90
- Registry id
- NCT06934538
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.